Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
03:50pm, Wednesday, 30'th Oct 2024
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for
Abbott Laboratories Employees Credit Union ("ALECU") Data Breach - Levi & Korsinsky, LLP Launches Investigation
12:15pm, Wednesday, 30'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 30, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of custom
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
08:36am, Wednesday, 30'th Oct 2024
Investors looking for health-related buy-and-hold stocks must look no further than this list. The stocks on this list are market leaders in healthcare, producing sustainable growth with healthy balanc
Levi & Korsinsky, LLP Investigates Abbott Laboratories Employees Credit Union ("ALECU") Data Breach
01:00pm, Tuesday, 29'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of custom
Here's Why You Should Retain ABT Stock in Your Portfolio Now
11:31am, Tuesday, 29'th Oct 2024
Investors feel optimistic about Abbott's robust strength in the Diagnostics and Nutrition business. Yet, unfavorable forex impacts are concerning.
My Best Dividend Aristocrats For November 2024
11:23am, Tuesday, 29'th Oct 2024
The ProShares S&P 500 Dividend Aristocrats ETF went on a great run during Q3, gaining 11.6% during the quarter. I present 3 strategies that can theoretically beat the dividend aristocrat index in the
ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock
09:11am, Tuesday, 29'th Oct 2024
Abbott initiates the TEAM-HF trial to improve outcomes for advanced heart failure.
Tidepool Will Integrate With Abbott's FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud Data
05:32pm, Monday, 28'th Oct 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool and Abbott collaborate to integrate data, expand patient choice, and improve clinical workflows.
Abbott Laboratories Employees Credit Union (“ALECU”) Data Breach under Investigation by Levi & Korsinsky
12:45pm, Monday, 28'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of custom
CORRECTING and REPLACING Tidepool Will Integrate With Abbott's FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud Data
09:54am, Monday, 28'th Oct 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool and Abbott partner to integrate data, expand patient choice, and improve clinical workflows.
3 Dividend Growth Stocks You Can Buy and Hold Forever
07:30am, Saturday, 26'th Oct 2024
These healthcare stocks have fantastic dividend track records.
FeganScott Launches Investigation into Abbott Laboratories Employees Credit Union Data Breach
04:15pm, Thursday, 24'th Oct 2024
CHICAGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Attorneys at the law firm FeganScott have launched an investigation into the Abbott Laboratories Employees Credit Union (ALEC) data breach, which, according
Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
09:00am, Thursday, 24'th Oct 2024
The first-of-its-kind TEAM-HF study seeks to improve clinical outcomes in patients with worsening heart failure Trial establishes new, objective criteria to identify patients most at risk for developi
Federman & Sherwood Investigates Abbott Laboratories Employees Credit Union (“ALEC”) for Data Breach
05:28pm, Wednesday, 23'rd Oct 2024
OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Investigates Abbott Laboratories Employees Credit Union (“ALEC”) for Data Breach.
Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt
01:21pm, Wednesday, 23'rd Oct 2024
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
